Changes in activin and activin receptor subunit expression in rat liver during the development of CCl4-induced cirrhosis

Molecular and Cellular Endocrinology

Volumn 201, Issue 1-2, 2003, Pages 143-153

  Gold, Elspeth J ^a   Francis, Richard J B ^a   Zimmermann, Arthur ^b   Mellor, Sally L ^c   Cranfield, Mark ^d   Risbridger, Gail P ^c   Groome, Nigel P ^d   Wheatley, Antony M ^a   Fleming, Jean S ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF BERN   (Switzerland)

^c MONASH UNIVERSITY   (Australia)

^d OXFORD BROOKES UNIVERSITY   (United Kingdom)

Author keywords

Apoptosis (rat liver); Cirrhosis; Fibrosis; Inhibin; TGF ; C activin

Indexed keywords

ACTIVIN; ACTIVIN A; ACTIVIN C; ACTIVIN RECEPTOR 2A; ACTIVIN RECEPTOR 2B; CARBON TETRACHLORIDE; MESSENGER RNA; PROTEIN SUBUNIT; RECEPTOR SUBUNIT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIVER CELL; LIVER CIRRHOSIS; LIVER NODULE; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 0037471182     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(02)00417-3     Document Type: Article

References (36)

1. Anthony P.P., Ishak K.G., Nayak N.C., Poulsen H.E., Scheuer P.J., Sobin L.H. The morphology of cirrhosis. Recommendations on definition, nomenclature, and classification by a working group sponsored by the World Health Organization. J. Clin. Pathol. 31:1978;395-414.
2. Batts K.P., Ludwig J. Chronic hepatitis: an update on terminology and reporting. Am. J. Surg. Pathol. 19:1995;1409-1417.
3. Coerver K.A., Woodruff T.K., Finegold M.J., Mather J., Bradley A., Matzuk M.M. Activin signaling through activin receptor type II causes the cachexia-like symptoms in inhibin-deficient mice. Mol. Endocrinol. 10:1996;534-543.
4. Dalkin A.C., Gilrain J.T., Marshall J.C. Ovarian regulation of pituitary inhibin subunit and activin receptor type II gene expression: evidence for a nonsteroidal inhibitory substance. Endocrinology. 135:1994;944-949.
5. Date M., Matsuzaki K., Matsushita M., Tahashi Y., Sakitani K., Inoue K. Differential regulation of activin A for hepatocyte growth and fibronectin synthesis in rat liver injury. J. Hepatol. 32:2000;251-260.
6. De Bleser P.J., Niki T., Xu G., Rogiers V., Geerts A. Localization and cellular sources of activins in normal and fibrotic rat liver. Hepatology. 26:1997;905-912.
7. de Kretser D.M., Hedger M.P., Phillips D.J. Activin A and follistatin: their role in the acute phase reaction and inflammation. J. Endocrinol. 161:1999;195-198.
8. Devereux J., Haeberli P., Smithies O. A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res. 12:1984;387-395.
9. Esquela A., Zimmers T., Koniaris L., Sitzmann J., Lee S.-J. Transient down-regulation of inhibin-βC expression following partial hepatectomy. Biochem. Biophys. Res. Commun. 235:1997;553-556.
10. Friedman S.L. Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis: mechanisms and treatment strategies. N. Engl. J. Med. 328:1993;1828-1835.
11. Hotten G., Neidhardt H., Schneider C., Pohl J. Cloning of a new member of the TGF-beta family: a putative new activin beta C chain. Biochem. Biophys. Res. Commun. 206:1995;608-613.
12. Hubner G., Alzheimer C., Werner S. Activin: a novel player in tissue repair processes. Histol. Histopathol. 14:1999;295-304.
13. Hully J.R., Chang L., Schwall R.H., Widmer H.R., Terrell T.G., Gillett N.A. Induction of apoptosis in the murine liver with recombinant human activin A. Hepatology. 20:1994;854-862.
14. Ishak K., Baptista A., Bianchi L., Callea F., De Groote J., Gudat F., Denk H., Desmet V., Korb G., MacSween R.N. Histological grading and staging of chronic hepatitis. J. Hepatol. 22:1995;696-699.
15. Matzuk M.M., Finegold M.J., Mather J.P., Krummen L., Lu H., Bradley A. Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice. Proc. Natl. Acad. Sci. USA. 91:1994;8817-8821.
16. Mellor S.L., Cranfield M., Ries R., Pedersen J., Cancilla B., de Kretser D., Groome N.P., Mason A.J., Risbridger G.P. Localization of activin beta(A)-, beta(B)-, and beta(C)-subunits in human prostate and evidence for formation of new activin heterodimers of beta(C)-subunit. J. Clin. Endocrinol. Metab. 85:2000;4851-4858.
17. Michalopoulos G.K. Liver regeneration: molecular mechanisms of growth control. FASEB J. 4:1990;176-187.
18. Moller S., Henriksen J.H. Circulatory abnormalities in cirrhosis with focus on neurohumoral aspects. Semin. Nephrol. 17:1997;505-519.
19. Montgomery J.M., Fleming J.S., Mills R.G. Evidence for a neural inhibitory factor which downregulates fetal-type acetylcholine receptor expression in skeletal muscle cell lines. Brain Res. 818:1999;346-354.
20. Munz B., Hubner G., Tretter Y., Alzheimer C., Werner S. A novel role of activin in inflammation and repair. J. Endocrinol. 161:1999;187-193.
21. Nudel U., Zakut R., Shani M., Neuman S., Levy Z., Yaffe D. The nucleotide sequence of the rat cytoplasmic beta-actin gene. Nucleic Acids Res. 11:1983;1759-1771.
22. Patella S., Phillips D.J., de Kretser D.M., Evans L.W., Groome N.P., Sievert W. Characterization of serum activin-A and follistatin and their relation to virological and histological determinants in chronic viral hepatitis. J. Hepatol. 34:2001;576-583.
23. 4 and adequate model of human cirrhosis? Hepatology. 3:1983;112-120.
24. Proctor E., Chatamra K. High yield micronodular cirrhosis in the rat. Gastroenterology. 83:1982;1183-1190.
25. Roulot D., Sevcsik A.M., Coste T., Strosberg A.D., Marullo S. Role of transforming growth factor beta type II receptor in hepatic fibrosis: studies of human chronic hepatitis C and experimental fibrosis in rats. Hepatology. 29:1999;1730-1738.
26. Schmitt J., Hotten G., Jenkins N.A., Gilbert D.J., Copeland N.G., Pohl J., Schrewe H. Structure, chromosomal localization, and expression analysis of the mouse inhibin/activin beta C (Inhbc) gene. Genomics. 32:1996;358-366.
27. Schwall R.H., Robbins K., Jardieu P., Chang L., Lai C., Terrell T.G. Activin induces cell death in hepatocytes in vivo and in vitro. Hepatology. 18:1993;347-356.
28. Siegel S. Nonparametric Statistics for the Behavioral Sciences. 1956;McGraw-Hill Kogakusha, Tokyo.
29. Sugiyama M., Ichida T., Sato T., Ishikawa T., Matsuda Y., Asakura H. Expression of activin A is increased in cirrhotic and fibrotic rat livers. Gastroenterology. 114:1998;550-558.
30. Woodruff T.K. Regulation of cellular and system function by activin. Biochem. Pharmacol. 55:1998;953-963.
31. Woodruff T.K., Meunier H., Jones P.B., Hsueh A.J., Mayo K.E. Rat inhibin: molecular cloning of alpha- and beta-subunit complementary deoxyribonucleic acids and expression in the ovary. Mol. Endocrinol. 1:1987;561-568.
32. Yasuda H., Mine T., Shibata H., Eto Y., Hasegawa Y., Takeuchi T., Asano S., Kojima I. Activin A: an autocrine inhibitor of initiation of DNA synthesis in rat hepatocytes. J. Clin. Invest. 92:1993;1491-1496.
33. Ying S.Y. Inhibins, activins, and follistatins: gonadal proteins modulating the secretion of follicle-stimulating hormone. Endocr. Rev. 9:1988;267-293.
34. Zhang Y.Q., Shibata H., Schrewe H., Kojima I. Reciprocal expression of mRNA for inhibin betaC and betaA subunits in hepatocytes. Endocr. J. 44:1997;759-764.
35. Zhao D., Zimmermann A., Wheatley A.M. Morphometry of the liver after liver transplantation in the rat: significance of an intact arterial supply. Hepatology. 17:1993;310-317.
36. Zhao D., Zimmermann A., Kuznetsova L.V., Wheatley A.M. Regression of bile duct damage and bile duct proliferation in the non-rearterialized transplanted rat liver is associated with spontaneous graft rearterialization. Hepatology. 21:1995;1353-1360.